JDP2, a Repressor of AP-1, Recruits a Histone Deacetylase 3 Complex To Inhibit the Retinoic Acid-Induced Differentiation of F9 Cells

REFERENCES

• Angel, P., and M. Karin. 1991. The role of Jun, Fos and AP-1 complex in cell proliferation and transformation. Biochim. Biophys. Acta 1072: 129–159.
   PubMed Web of Science ®Google Scholar
• Aronheim, A., E. Zandi, H. Hennemann, S. J. Elledge, and M. Karin. 1997. Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions. Mol. Cell. Biol. 17: 3094–3102.
   PubMed Web of Science ®Google Scholar
• Bannister, A. J., and T. Kouzarides. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384: 641–643.
   PubMed Web of Science ®Google Scholar
• Bersteine, E. G., M. L. Hooper, S. Grandchamp, and B. Ephrussi. 1973. Alkaline phosphatase activity in the differentiation of mouse teratoma. Proc. Natl. Acad. Sci. USA 70: 3899–3903.
   PubMedGoogle Scholar
• Bossy-Wetzel, E., and M. Yaniv. 1997. Induction of apoptosis by the transcription factor c-Jun. EMBO J. 16: 1695–1709.
   PubMed Web of Science ®Google Scholar
• Braunstein, M., A. B. Rose, S. G. Holmes, C. D. Allis, and J. R. Broach. 1993. Transcriptional silencing in yeast is associated with reduced nucleosome acetylation. Genes Dev. 7: 592–604.
   PubMed Web of Science ®Google Scholar
• Dahiya, A., M. R. Gavin, R. X. Luo, and D. C. Dean. 2000. Role of the LXCXE binding site in Rb function. Mol. Cell. Biol. 20: 6799–6805.
   PubMed Web of Science ®Google Scholar
• Dangond, F., D. A. Hafler, J. K. Tong, J. Randall, N. Utku, and S. R. Gullans. 1998. Differential display cloning of a novel human histone deacetylase (HDAC3) cDNA from PHA-activated immune cells. Biochem. Biophys. Res. Commun. 26: 648–652.
   Google Scholar
• de Groot, R. P., J. Schoorlemmer, S. T. van Genesen, and W. Kruijer. 1990. Differential expression of jun and fos genes during differentiation of mouse P19 embryonal carcinoma cells. Nucleic Acids Res. 18: 3195–3202.
   PubMedGoogle Scholar
• de Groot, R. P., F. A. E. Kruyt, S. T. van Genesen, and W. Kruijer. 1990. Ectopic expression of c-jun leads to differentiation of P19 embryonal carcinoma cells. EMBO J. 9: 1831–1837.
   PubMed Web of Science ®Google Scholar
• Eckner, R., T.-S. Yao, E. Oldread, and D. M. Livingston. 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated p300-kDa protein (p300) reveal a protein with properties of a transcriptional adapter. Genes Dev. 8: 869–884.
   PubMed Web of Science ®Google Scholar
• Emiliani, S., W. Fischle, C. van Lint, Y. Al-Abed, and E. Verdin. 1998. Characterization of a human RPD3 ortholog, HDAC3. Proc. Natl. Acad. Sci. USA 95: 2795–2800.
   PubMed Web of Science ®Google Scholar
• Gibson, U. E., C. A. Heid, and P. M. Williams. 1996. A novel method for real-time quantitative RT-PCR. Genome Res. 6: 995–1001.
   PubMed Web of Science ®Google Scholar
• Gray, S. G., and T. J. Ekström. 2001. The human histone deacetylase family. Exp. Cell Res. 262: 75–83.
   PubMed Web of Science ®Google Scholar
• Grunstein, M. 1997. Histone acetylation in chromatin structure and transcription. Nature 389: 349–353.
   PubMed Web of Science ®Google Scholar
• Guenther, M. G., W. S. Lane, W. Fischle, E. Verdin, M. A. Lazar, and R. Shiekhattar. 2000. A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev. 14: 1048–1057.
   PubMed Web of Science ®Google Scholar
• Guenther, M. G., O. Barak, and M. A. Lazar. 2001. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol. Cell. Biol. 21: 6091–6101.
   PubMed Web of Science ®Google Scholar
• Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Hilberg, F., A. Aguzzi, N. Howells, and E. F. Wagner. 1993. c-Jun is essential for normal mouse development and hepatogenesis. Nature 365: 179–181.
   PubMed Web of Science ®Google Scholar
• Jin, C., H. Ugai, J. Song, T. Murata, F. Nili, K. Sun, M. Horikoshi, and K. K. Yokoyama. 2001. Identification of mouse Jun dimerization protein 2 as a novel repressor of ATF-2. FEBS Lett. 489: 34–41.
   PubMedGoogle Scholar
• Johnson, R. S., B. van Lingen, V. E. Papaioannou, and B. M. Spiegelman. 1993. A null mutation of the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev. 7: 1309–1317.
   PubMed Web of Science ®Google Scholar
• Karin, M., Z. G. Liu, and E. Zandi. 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9: 240–246.
   PubMed Web of Science ®Google Scholar
• Kawasaki, H., J. Song, R. Eckner, H. Ugai, R. Chiu, K. Taira, Y. Shi, N. Jones, and K. K. Yokoyama. 1998. p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells. Genes Dev. 12: 233–245.
   PubMedGoogle Scholar
• Kawasaki, H., R. Eckner, T.-P. Yao, K. Taira, R. Chiu, D. M. Livingston, and K. Yokoyama. 1998. Distinct roles of the co-activators p300 and CBP in retinoic acid-induced F9 cell differentiation. Nature 393: 284–289.
   PubMed Web of Science ®Google Scholar
• Kitabayashi, I., R. Chiu, G. Gachelin, and K. Yokoyama. 1991. E1A-dependent up-regulation of c-jun/AP-1 activity. Nucleic Acids Res. 19: 649–655.
   PubMedGoogle Scholar
• Kitabayashi, I., Z. Kawakami, R. Chiu, K. Ozawa, T. Matsuoka, S. Toyoshima, K. Umesono, R. M. Evans, G. Gachelin, and K. Yokoyama. 1992. Transcriptional regulation of the c-jun gene by retinoic acid and E1A during differentiation of F9 cells. EMBO J. 11: 167–175.
   PubMedGoogle Scholar
• Kitabayashi, I., R. Chiu, K. Umezono, G. Gachelin, R. M. Evans, and K. K. Yokoyama. 1994. A novel pathway for RA-induced differentiation of F9 cells that is independent of receptor-mediated transactivation. In Vitro Cell. Dev. Biol. 30A: 761–768.
   Google Scholar
• Kitabayashi, I., R. Eckner, Z. Arany, R. Chiu, G. Gachelin, D. M. Livingston, and K. K. Yokoyama. 1995. Phosphorylation of the adenovirus E1A-associated 300-kDa protein in response to retinoic acid and E1A during the differentiation of F9 cells. EMBO J. 14: 3496–3509.
   PubMedGoogle Scholar
• Langston, A. W., and L. J. Gudas. 1992. Identification of a retinoic acid-responsive enhancer 3′ of the murine homeobox gene Hox-1.6. Mech. Dev. 38: 217–228.
   PubMedGoogle Scholar
• Li, J., J. Wang, Z. Nawaz, J. M. Liu, J. Qin, and J. Wang. 2000. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 19: 4342–4350.
   PubMed Web of Science ®Google Scholar
• Nagy, L., H. Y. Kao, D. Chakravarti, R. J. Lin, C. A. Hassig, D. E. Ayer, S. L. Schreiber, and R. M. Evans. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89: 373–380.
   PubMed Web of Science ®Google Scholar
• Ng, H. H., and A. Bird. 2001. Histone deacetylases silences for hire. Trends Biochem. Sci. 25: 121–126.
   Google Scholar
• Ogryzko, V. W., R. L. Schiltz, V. Russanova, R. H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953–959.
   PubMed Web of Science ®Google Scholar
• Piu, F., A. Aronheim, S. Katz, and M. Karin. 2001. AP-1 repressor protein JDP-2: inhibition of UV-mediated apoptosis through p53 down-regulation. Mol. Cell. Biol. 21: 3012–3024.
   PubMedGoogle Scholar
• Schreiber, M., A. Kolbus, F. Piu, A. Szabowski, U. Möhle-Steinlein, J. Tian, M. Karin, P. Angel, and E. F. Wagner. 1999. Control of cell cycle progression by c-Jun is p53-dependent. Genes Dev. 13: 607–619.
   PubMed Web of Science ®Google Scholar
• Strickland, S., and V. Mahdavi. 1978. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15: 393–403.
   PubMed Web of Science ®Google Scholar
• Underhill, C., M. S. Qutob, S. P. Yee, and J. Torchia. 2000. A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1. J. Biol. Chem. 275: 40463–40470.
   PubMedGoogle Scholar
• Urnov, F. D., J. Yee, L. Sachs, T. N. Collingwood, A. Bauer, H. Beug, Y. B. Shi, and A. P. Wolffe. 2000. Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway. EMBO J. 19: 4074–4090.
   PubMedGoogle Scholar
• Vogt, T. P., and J. Bos. 1990. Jun: oncogene and transcriptional factor. Adv. Cancer Res. 55: 1–35.
   PubMedGoogle Scholar
• Wang, S.-Y., and L. J. Gudas. 1983. Isolation of cDNA clones specific for collagen IV and laminin from mouse teratocarcinoma cells. Proc. Natl. Acad. Sci. USA 80: 5880–5884.
   PubMedGoogle Scholar
• Wei, L. N., X. Hu, D. Chandra, E. Seto, and M. Farooqui. 2000. Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing. J. Biol. Chem. 275: 40782–40787.
   PubMedGoogle Scholar
• Wen, Y. D., V. Perissi, L. M. Staszewski, W. M. Yang, A. Krones, C. K. Glass, M. G. Rosenfeld, and E. Seto. 2000. The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc. Natl. Acad. Sci. USA 97: 7202–7207.
   PubMed Web of Science ®Google Scholar
• Wilkinson, D. G., S. Bhatt, R. P. Ryseck, and R. Bravo. 1989. Tissue-specific expression of c-jun and JunB during organogenesis in the mouse. Development 106: 465–471.
   PubMed Web of Science ®Google Scholar
• Yamaguchi-Iwai, Y., M. Satake, Y. Murakami, M. Sakai, M. Muramatsu, and Y. Ito. 1990. Differentiation of F9 embryonal carcinoma cells induced by the c-jun and activated c-Ha-ras oncogenes. Proc. Natl. Acad. Sci. USA 87: 8670–8674.
   PubMed Web of Science ®Google Scholar
• Yang, X. J., V. V. Ogryzko, J. Nishikawa, B. H. Howard, and Y. Nakatani. 1996. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382: 319–324.
   PubMed Web of Science ®Google Scholar
• Yang-Yen, H. F., R. Chiu, and M. Karin. 1990. Elevation of AP-1 activity during F9 cell differentiation is due to increased c-jun transcription. Nat. New Biol. 2: 351–361.
   Google Scholar
• Yong, M. R., J.-J. Li, M. Rincon, R. A. Flavell, B. K. Sashyanarayana, R. Hunziker, and N. Colburn. 1999. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc. Natl. Acad. Sci. USA 96: 9827–9832.
   PubMedGoogle Scholar